Over the last 7 days, the Biotech industry has remained flat, although notably Regeneron Pharmaceuticals gained 3.3%. The past year has been better, since the industry has gained 6.7% in that time. Earnings are forecast to grow by 25% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 15 Jun 2024 | US$1.2t | US$164.4b | -US$28,065,533,148.41 | 27.3x | -41.3x | 7.1x |
Mon, 13 May 2024 | US$1.1t | US$164.6b | -US$26,961,785,793.98 | 23.3x | -41.2x | 6.7x |
Wed, 10 Apr 2024 | US$1.1t | US$164.4b | -US$23,371,088,407.86 | 21.5x | -48.3x | 6.9x |
Fri, 08 Mar 2024 | US$1.2t | US$167.5b | -US$21,885,421,990.22 | 18.8x | -54.5x | 7.1x |
Sun, 04 Feb 2024 | US$1.4t | US$203.9b | -US$24,418,168,728.00 | 19.2x | -58.9x | 7.1x |
Tue, 02 Jan 2024 | US$1.4t | US$204.9b | -US$22,203,182,413.00 | 19.8x | -62.5x | 6.8x |
Thu, 30 Nov 2023 | US$1.2t | US$204.8b | -US$22,009,160,710.00 | 18.1x | -55.4x | 6x |
Sat, 28 Oct 2023 | US$1.2t | US$206.6b | -US$15,166,070,486.00 | 16.3x | -77.7x | 5.7x |
Mon, 25 Sep 2023 | US$1.3t | US$207.5b | -US$12,879,333,723.00 | 17.1x | -97.9x | 6.1x |
Wed, 23 Aug 2023 | US$1.3t | US$207.6b | -US$12,453,450,426.00 | 17.4x | -102.7x | 6.2x |
Fri, 21 Jul 2023 | US$1.1t | US$186.5b | -US$16,008,267,080.00 | 12.7x | -71.5x | 6.1x |
Sun, 18 Jun 2023 | US$1.2t | US$186.3b | -US$16,045,332,946.00 | 12.1x | -72.3x | 6.2x |
Tue, 16 May 2023 | US$1.2t | US$191.8b | -US$12,215,533,598.00 | 13.8x | -95.7x | 6.1x |
Thu, 13 Apr 2023 | US$1.2t | US$198.5b | -US$3,250,698,650.00 | 14x | -357.1x | 5.8x |
Sat, 11 Mar 2023 | US$1.1t | US$199.3b | -US$4,751,094,936.00 | 14.9x | -230.3x | 5.5x |
Mon, 06 Feb 2023 | US$1.2t | US$202.3b | US$1.9b | 16.3x | 624.5x | 5.7x |
Wed, 04 Jan 2023 | US$1.1t | US$203.2b | US$1.6b | 14.3x | 722.7x | 5.6x |
Fri, 02 Dec 2022 | US$1.2t | US$202.6b | US$1.4b | 15.2x | 814.9x | 5.7x |
Sun, 30 Oct 2022 | US$1.1t | US$205.9b | US$7.4b | 14.3x | 148.7x | 5.3x |
Tue, 27 Sep 2022 | US$999.8b | US$205.8b | US$5.5b | 13.8x | 181.9x | 4.9x |
Thu, 25 Aug 2022 | US$1.1t | US$206.2b | US$7.3b | 16x | 147.3x | 5.2x |
Sat, 23 Jul 2022 | US$1.1t | US$211.4b | US$11.3b | 16.6x | 95.9x | 5.1x |
Mon, 20 Jun 2022 | US$952.1b | US$212.2b | US$10.9b | 14.8x | 87x | 4.5x |
Wed, 18 May 2022 | US$999.2b | US$212.2b | US$10.9b | 16.4x | 91.7x | 4.7x |
Fri, 15 Apr 2022 | US$1.3t | US$226.7b | US$14.8b | 18.6x | 86.2x | 5.6x |
Sun, 13 Mar 2022 | US$1.2t | US$222.1b | US$10.5b | 18.7x | 114.3x | 5.4x |
Tue, 08 Feb 2022 | US$1.3t | US$216.1b | US$6.2b | 21.8x | 202.9x | 5.9x |
Thu, 06 Jan 2022 | US$1.4t | US$212.0b | US$2.8b | 25.9x | 505.6x | 6.6x |
Sat, 04 Dec 2021 | US$1.4t | US$211.9b | US$3.1b | 25.1x | 460.4x | 6.6x |
Mon, 01 Nov 2021 | US$1.5t | US$196.6b | -US$2,981,915,412.00 | 26.2x | -504.3x | 7.6x |
Wed, 29 Sep 2021 | US$1.5t | US$196.4b | -US$2,413,259,749.00 | 24.3x | -631.6x | 7.8x |
Fri, 27 Aug 2021 | US$1.6t | US$197.0b | -US$1,734,385,785.58 | 22x | -917.7x | 8.1x |
Sat, 03 Jul 2021 | US$1.5t | US$196.9b | -US$825,939,314.84 | 25.2x | -1810.8x | 7.6x |
-1810.8x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.21% | |
Healthcare | -0.42% | |
Biotech | 0.023% | |
Biotech | 0.023% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
REGN Regeneron Pharmaceuticals | US$1.04k | 3.3% +US$3.6b | 32.4% | PE29x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
RNA Avidity Biosciences | US$39.64 | 49.0% +US$1.2b | 227.1% | PS348.8x | |
INSM Insmed | US$63.92 | 12.4% +US$1.1b | 219.6% | PS32.7x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |